Navigation Links
Gerresheimer Expands its Pharmaceutical Plastic Operations Into Southern Europe and South America
Date:12/21/2007

Consistent Continuation of Globalisation Path and Extension of Product

Offerings

DUSSELDORF, Germany, December 21 /PRNewswire-FirstCall/ -- Gerresheimer AG is consistently continuing its strategy of globalisation and extension of product offerings in the pharma and life-science sector. With the acquisition of the Spanish company EDP S.A. it gains a leading manufacturer of pharmaceutical plastic packaging which contributes to the Group a total of three plants in Southern Europe and South America. "Regional expansion opens up important new growth markets for our Plastic Systems Division. At the same time, EDP ideally complements our existing product portfolio thus offering globally exploitable synergies," comments Gerresheimer CEO Dr. Axel Herberg. The transaction is expected to be completed at the end of January 2008.

As a leading specialist for pharmaceutical primary packaging and application systems, Gerresheimer has for a considerable time enjoyed a strong position with glass products like syringe systems and pharmaceutical vials; in parallel it has expanded its pharmaceutical and medical plastics business, so far in Europe particularly. The acquisition of the new company specialising in plastic substantially expands its sphere of activity in this segment.

EDP with production plants in Spain (Zaragoza and Valencia) and Argentina (Buenos Aires) concentrates on PET containers for the pharmaceutical industry and is the market leader in this important field. This company's annual sales total around EUR32m.

The products of the EDP company provide an ideal match, which will by no means be limited to the local markets. Pharma packaging based on PET, as produced by EDP in Spain and Argen­tina, represents a real range expansion, which Gerresheimer can complement with drug delivery systems to provide a system approach. At the same time, the Spanish and South American markets of the new subsidiary are opened up for innovative packaging and system technologies from existing Gerresheimer plants. Gerresheimer's pharmaceutical plastics business ranks among the market leaders, so far in Europe particularly.

As Herberg stresses, full integration of the new company into the Group is to be completed in the first half of 2008. The new subsidiary currently achieves an EBITDA margin of around 17%. Through targeted technical and financial optimisation measures the EBITDA margin should be increased to well above 20%.

About Gerresheimer

Gerresheimer employs around 10,000 people in 37 locations across Europe, America and Asia. The Group's product range extends from glass and plastic medicine bottles to complex drug-delivery systems for the pharma and life-science industries. The product spectrum includes sterile syringes, inhalers and other system-based solutions for safer dosage and delivery of medications. The Group enjoys a leading position in a market which is characterised by high technical and regulatory barriers and where Gerresheimer's products must satisfy the strictest quality standards of the international pharmaceutical supervisory bodies. The Group achieves worldwide sales of more than EUR950m.

Contact

Burkhard Lingenberg

Director Corporate PR & Marketing

Telephone: +49-211-6181-250

Telefax: +49-211-6181-241

e-mail: b.lingenberg@gerresheimer.com

Internet: http://www.gerresheimer.com


'/>"/>
SOURCE Gerresheimer AG
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Gerresheimer to be Included in the SDAX Early Decision on Inclusion in the MDAX on September 5, 2007
2. Growth Trend for Gerresheimer Continues Unabated - Debt Reduction
3. Linnartz New Head of Investor Relations of Gerresheimer
4. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
5. Rohm and Haas Expands in India
6. Concentra Expands Horizon Air Employee Health Program With On-Site Clinic
7. Regional Center of Orange County Expands Family Support Resources to Meet Growing Needs
8. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
9. Specialty Blades, Inc. Expands Management Team With New VP Engineering
10. CRH Medical expands Las Vegas operations
11. US Med-Equip Expands Corporate Support Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star ... , Millions of individuals in the United States and Canada wear eyeglasses. Once considered ... both correct vision and make a fashion statement. Even celebrities use glasses as a ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June ... , brings up a new, often overlooked aspect of head lice: the parasite’s ability to ... is not a common occurrence, but a necessary one in the event that lice have ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology ... a new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ... to list on the ASX. Noxopharm is a clinic-ready ... a Phase 1 clinical study later this year. ... the biggest problems facing cancer patients - the ability of cancers ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
Breaking Medicine Technology: